Azenta, Inc. (AZTA)
Azenta, Inc. (ticker AZTA) is a life sciences equipment and services company serving the pharmaceutical, biotechnology, and medical research sectors through cold storage solutions, sample management systems, and cryogenic storage infrastructure.
What the company does
Azenta operates two main business segments focused on supporting the global life sciences ecosystem. The company manufactures and sells cold storage and sample management systems, including ultra-low freezers, cryo-preservation systems, and liquid nitrogen storage solutions. These products maintain biological samples, cell cultures, and pharmaceutical ingredients at controlled temperatures, often below negative 150 degrees Celsius. Beyond equipment, Azenta provides complementary services such as specimen management software, data management systems, and maintenance support contracts to laboratories, hospitals, research institutions, and contract research organizations.
How it makes money
The company generates revenue through equipment sales and recurring service contracts. Sales of cryogenic storage systems and freezers represent a significant portion of revenue, while installation, maintenance, software licensing, and long-term service agreements provide ongoing cash flows. Azenta also serves clinical trial sponsors and clinical laboratories through its management of patient samples and test results, creating additional service-based revenue streams beyond pure equipment sales.
Where it sits in its industry
Azenta is a major supplier of cold storage and sample management solutions in a critical niche of the life sciences sector. Its competitors include traditional lab equipment manufacturers and newer entrants focused on automation and data analytics. The company’s dual focus on hardware and software-enabled services positions it within a broader trend toward integrated laboratory information management. Sample integrity and compliance with regulatory standards drive consistent demand, as life sciences organizations must reliably preserve specimens for research, clinical trials, diagnostics, and manufacturing processes.
Growth drivers
The expansion of biobanking, personalized medicine, and cell therapy research has sustained demand for advanced sample preservation. Regulatory requirements for sample traceability and storage documentation create recurring revenue opportunities through software and compliance services. Geographic expansion into emerging markets and deepening penetration in established research hubs support growth trajectories.
How to research it
Start with Azenta’s annual 10-K filing submitted to the SEC, which details revenue composition, capital expenditure, and segment performance. Quarterly 10-Q filings offer interim updates on bookings, order backlogs, and operational metrics. Investor presentations and earnings call transcripts provide management commentary on competitive positioning and strategic initiatives. Industry reports from life sciences research firms outline trends in sample management and cold storage demand. Patent filings reveal the company’s innovation pipeline in cryogenic and automation technologies.